bismuth - CISMeF

Preferred Label : bismuth;

MeSH definition : A metallic element that has the atomic symbol Bi, atomic number 83 and atomic weight 208.98.; A metallic element that has the atomic symbol Bi, and atomic number 83. Its principal isotope is Bismuth 209.;

MeSH CAS label : bismuth;

MeSH Related Number : 7440-69-9 (Bismuth);

Registry Number MeSH : 7440-69-9;

MeSH annotation : Bi-209; Bi-199-208, 210-215 BISMUTH (IM) RADIOISOTOPES (IM);

Wikipedia link : https://en.wikipedia.org/wiki/Bismuth;

Codes EINECS : 231-177-4;

Is substance : O;

medicament (CISMeF) : O;

UNII : U015TT5I8H;

InChIKey : JCXGWMGPZLAOME-UHFFFAOYSA-N;

Details

Origin ID

D001729;

UMLS CUI

C0005642;

ATC code(s)
- bismuth preparations [ATC Code]
- bismuth preparations, combinations [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- bismuth [Substance BNPC]
Currated CISMeF NLP mapping
- Bismuth [SMS substance]
- Bismuth [NCIt concept]
- Bismuth [LOINC component]
- Bismuth (substance) [SNOMED CT concept]
- bismuth [Radlex concept]
- bismuth, nos [SNOMED Notion]
Indexing information
- (213)Bi-CHX-A-diethylenetriamine pentaacetic acid-HuM195 [MeSH Supplementary Concept]
- (213)Bi-DTPA-F3 [MeSH Supplementary Concept]
- (ciprofloxacin)2(Bi2Cl10) [MeSH Supplementary Concept]
- 1,2-bis(2-(1,3-dithiobismolane)thio)ethane [MeSH Supplementary Concept]
- 1-((2-di-p-tolylbismuthanophenyl)diazenyl)pyrrolidine [MeSH Supplementary Concept]
- 213Bi-cDTPA-9.2.27 monoclonal antibody [MeSH Supplementary Concept]
- Bi(OTf)3 [MeSH Supplementary Concept]
- MX(1) complex [MeSH Supplementary Concept]
- N-(3-(3-(1-piperidinyl-methyl)phenoxy)propyl)hydroxyacetamide 2-hydroxypropane-1,2,3-tricarboxylate bismuth (3+) complex [MeSH Supplementary Concept]
- bicitropeptide [MeSH Supplementary Concept]
- bis(mu(3)-1,3,5-triamino-1,3,5-trideoxy-cis-inositolato(3-))tribismuth(III) trichloride hexahydrate [MeSH Supplementary Concept]
- bis(mu-pyridine-2,6-dicarboxylato)-kappa4O2,N,O6-O6'-kappa4O2-O2',N,O6-bis((azido-kappaN)(1,10-phenanthroline-kappa2N,N')bismuth(III))tetrahydrate [MeSH Supplementary Concept]
- bismoverol [MeSH Supplementary Concept]
- bismuth selenide [MeSH Supplementary Concept]
- bismuth silanolate [MeSH Supplementary Concept]
- bismuth subgallate [MeSH Supplementary Concept]
- bismuth tripotassium dicitrate [MeSH Supplementary Concept]
- bismuth(III)-ciprofloxacin 1 [MeSH Supplementary Concept]
- bismuth-6-mercaptopurine [MeSH Supplementary Concept]
- bismuth-binding proteins [MeSH Supplementary Concept]
- bismuth-norfloxacin [MeSH Supplementary Concept]
- dimethylammonium nonaiododibismuthate [MeSH Supplementary Concept]
- substance P, 213Bi-DOTA(thienylalanyl(8)-methionyl(O2)(11))- [MeSH Supplementary Concept]
- sucrose octasulfate [MeSH Supplementary Concept]
- tricyclopropylbismuth [MeSH Supplementary Concept]
- trimethylbismuth [MeSH Supplementary Concept]
- triphenyl bismuth [MeSH Supplementary Concept]
- triphenylbismuthdichloride [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
- Bismuth salt (substance) [Inactive SNOMED CT concept]
Pharmacological action(s)
- antacids [MeSH Descriptor]
Record concept(s)
- bismuth [MeSH concept]
Related MeSH Supplementary Concept(s)
- Bi(2)MoO(6) [MeSH Supplementary Concept]
- Bi2O2Se [MeSH Supplementary Concept]
- Bismuth-204 [MeSH Supplementary Concept]
- Bismuth-205 [MeSH Supplementary Concept]
- Bismuth-206 [MeSH Supplementary Concept]
- Bismuth-207 [MeSH Supplementary Concept]
- Bismuth-209 [MeSH Supplementary Concept]
- Bismuth-210 [MeSH Supplementary Concept]
- Bismuth-212 [MeSH Supplementary Concept]
- Bismuth-213 [MeSH Supplementary Concept]
- Bismuth-214 [MeSH Supplementary Concept]
- Bi₇O₉I₃ [MeSH Supplementary Concept]
- CH61 sealer [MeSH Supplementary Concept]
- MTA-Angelus [MeSH Supplementary Concept]
- PH.3 [MeSH Supplementary Concept]
- Proco-Sol [MeSH Supplementary Concept]
- aluminum hydroxide, bismuth subnitrate, deglycyrrhizinised liquorice, magnesium carbonate, sodium bicarbonate drug combination [MeSH Supplementary Concept]
- attapulgite, bismuth subcarbonate, kanamycin, drug combination [MeSH Supplementary Concept]
- bismacine [MeSH Supplementary Concept]
- bismuth aluminate [MeSH Supplementary Concept]
- bismuth aluminate, fennel, frangula bark, liquorice, magnesium carbonate, sodium bicarbonate drug combination [MeSH Supplementary Concept]
- bismuth carbonate [MeSH Supplementary Concept]
- bismuth dimercaptopropanol [MeSH Supplementary Concept]
- bismuth germanium oxide [MeSH Supplementary Concept]
- bismuth iodide [MeSH Supplementary Concept]
- bismuth iodoform paraffin paste [MeSH Supplementary Concept]
- bismuth lead [MeSH Supplementary Concept]
- bismuth nitrate [MeSH Supplementary Concept]
- bismuth orthovanadate [MeSH Supplementary Concept]
- bismuth oxide [MeSH Supplementary Concept]
- bismuth oxybromide [MeSH Supplementary Concept]
- bismuth oxychloride [MeSH Supplementary Concept]
- bismuth phosphate [MeSH Supplementary Concept]
- bismuth phosphate, copolymers of vinyl acetate, dichlorophen, propionyl-acetophenone, triethanolamine, vinyl chloride, vinylisobutyl ether, zinc oxide drug combination [MeSH Supplementary Concept]
- bismuth pyrostannate [MeSH Supplementary Concept]
- bismuth selenide [MeSH Supplementary Concept]
- bismuth subcarbonate [MeSH Supplementary Concept]
- bismuth subnitrate [MeSH Supplementary Concept]
- bismuth subnitrite [MeSH Supplementary Concept]
- bismuth subsalicylate [MeSH Supplementary Concept]
- bismuth sulfide [MeSH Supplementary Concept]
- bismuth telluride [MeSH Supplementary Concept]
- bismuth titanate [MeSH Supplementary Concept]
- bismuth trichloride [MeSH Supplementary Concept]
- bismuth vanadium tetraoxide [MeSH Supplementary Concept]
- bismuth wolframate [MeSH Supplementary Concept]
- boron-doped bismuth oxybromide [MeSH Supplementary Concept]
- dentinol [MeSH Supplementary Concept]
- epoxy resin AH-26 [MeSH Supplementary Concept]
- fillcanal [MeSH Supplementary Concept]
- herbazol [MeSH Supplementary Concept]
- mixite [MeSH Supplementary Concept]
- mynol C-T [MeSH Supplementary Concept]
- nilacid antacid [MeSH Supplementary Concept]
- penta-bismuth hepta-oxide nitrate [MeSH Supplementary Concept]
- plasmutan [MeSH Supplementary Concept]
- potassium tetraiodobismuthate [MeSH Supplementary Concept]
- ranitidine bismuth citrate [MeSH Supplementary Concept]
- sealer 26 [MeSH Supplementary Concept]
- strontium bismuth oxide [MeSH Supplementary Concept]
- strontium bismuth vanadium niobate [MeSH Supplementary Concept]
- tricatechol hexalactam-bismuth(III) complex [MeSH Supplementary Concept]
- trisibam [MeSH Supplementary Concept]
- uplex [MeSH Supplementary Concept]
See also inter- (CISMeF)
- blood bismuth levels [CISMeF Querying Strategy]
Semantic type(s)
- Element, Ion, or Isotope [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Bismuth [LOINC component]
- Bismuth [NCIt concept]
- Bismuth (substance) [SNOMED CT concept]
- Product containing bismuth (medicinal product) [SNOMED CT concept]
- bismuth [Substance BNPC]
- bismuth [Radlex concept]
- bismuth, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients